Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from SS Innovations International ( (SSII) ).
On October 21, 2025, SS Innovations International announced that its executives, Dr. Sudhir Srivastava and Dr. Vishwa Srivastava, will participate in upcoming investor conferences, including the UBS Global Healthcare Conference on November 11, 2025, and the Stifel 2025 Healthcare Conference on November 12, 2025. These events will provide opportunities for one-on-one and small group meetings, and a live webcast of the Stifel presentation will be available on the company’s website. This participation underscores the company’s commitment to engaging with investors and stakeholders, potentially enhancing its industry positioning and visibility.
The most recent analyst rating on (SSII) stock is a Hold with a $9.50 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.
SS Innovations International’s stock score is primarily influenced by its financial performance challenges, particularly in profitability and cash flow management. Despite strong revenue growth, the negative P/E ratio and lack of dividend yield weigh heavily on the valuation score. Technical analysis shows bullish momentum, but potential overbought conditions could pose risks.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. (Nasdaq: SSII) is a developer of innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. The company’s product lineup includes the ‘SSi Mantra’ surgical robotic system and the ‘SSi Mudra’ surgical instruments, which are designed to support a variety of surgical procedures, including robotic cardiac surgery. Headquartered in India, the American company is focused on expanding its global presence with its advanced, user-friendly, and cost-effective solutions.
Average Trading Volume: 81,049
Technical Sentiment Signal: Buy
Current Market Cap: $1.93B
Learn more about SSII stock on TipRanks’ Stock Analysis page.